Post-Graphene 2D Materials: Structures, Properties, and Cancer Therapy Applications

Fei Kuang1, Tiankun Hui2, Yingjie Chen2

  • 1College of Life Sciences, Qingdao University, No.308 Ningxia Road, Qingdao, Shandong, 266071, China.

PubMed

Insights

Emerging two-dimensional nanomaterials (2D nanomaterials) offer promising advancements in targeted cancer therapy due to their unique properties. This review explores their potential for synergistic treatments and overcoming current challenges in oncology.

Area of Science:

  • Materials Science
  • Nanotechnology
  • Oncology

Background:

  • Cancer remains a leading global health challenge, necessitating innovative treatment strategies.
  • Early diagnosis and effective therapies are crucial for improving patient survival rates.
  • Two-dimensional nanomaterials (2D nanomaterials) exhibit unique physicochemical properties making them promising for cancer treatment.

Purpose of the Study:

  • To review the advantages and applications of emerging 2D nanomaterials in targeted tumor synergistic therapy.
  • To explore surface modification, cargo delivery, and optical properties of 2D nanomaterials for novel anticancer strategies.
  • To summarize current challenges and future prospects in nanomedicine for cancer treatment.

Main Methods:

  • Review of recent scientific literature on 2D nanomaterials in cancer therapy.
  • Analysis of surface modification techniques for targeted drug delivery.
  • Evaluation of the physicochemical and optical properties of 2D nanomaterials for therapeutic applications.

Main Results:

  • 2D nanomaterials offer unique advantages over traditional cancer therapies due to their large surface area and tunable properties.
  • Surface modification enhances targeted delivery and efficacy of 2D nanomaterials in synergistic cancer treatment.
  • Unique optical properties of 2D nanomaterials can be leveraged for advanced diagnostic and therapeutic applications.

Conclusions:

  • Emerging 2D nanomaterials show significant potential for revolutionizing targeted tumor synergistic therapy.
  • Further research into surface modification and cargo delivery is essential for clinical translation.
  • Addressing current challenges will pave the way for advanced nanomedicine-based cancer treatments.